Monitoring and evaluation through analysis and reporting of quality indicators is an integral part of any health policy.
Evaluate national action plan on antimicrobial resistance
In order to ensure that implementation of the national action plan on resistance occurs as planned, continuous monitoring is important. Results should be fed back to government parties and members of the stakeholder platform in a timely manner and in a format that can be interpreted and used by the respective party. Periodic evaluation is important to understand if goals are being accomplished and to identify aspects that may need improvement.
Develop a monitoring and evaluation plan
When monitoring health reforms, assessments of the level of inputs (financial, human, and logistics), the dynamics, processes and the outputs of implementation are in focus. Evaluation then assesses the extent to which the policy’s different activities has achieved the outcome and impact objectives. In other words, if the policy has had the effect it intended and what could be addressed and improved.
Often evaluation is done by measuring indicators, however, in addition, the collection of descriptive data can be helpful to give a comprehensive view of the extent to which changes are occurring. When developing a monitoring and evaluation framework, the multisectoral coordinating group should consider:
- What is the specific aim(s) of the policy/intervention?
- What measure(s) monitor the policy implementation process?
- What measure(s) would show progress in achieving stated aims?
- How to collect and record such data?
- Who will analyze and interpret the data?
- How does the results of such data then influence stakeholders and/or policy?
Measurement and indicators
An essential part of the planning of the monitoring and evaluation plan is the development of adequate indicators. Indicators are key in documenting progress and can be used to compare and benchmark against other countries, and in between regions. Clear indicators give external stakeholders a possibility to put pressure on policy makers to actually take action. It is important that indicators represent the progress towards implementing the activity or achieving the outcome. . Indicators used to monitor implementation of the antibiotic resistance policy can be divided into five different groups:
Indicator Groups for Monitoring and Evaluation:
|Input||Indicators measuring resources used/needed in implementing policy||Financial cost of:
|Process||Indicators measuring action points relating to programme implementation||
|Output||Indicators measuring the number or presence of intended products/outputs||
|Outcome||Indicators that assess the quantity and quality of the policy implemented||
|Impact||Indicators assessing the achievement of longer term goals relating to broader policy aims||
Implementation plan, indicators and targets for WHO South East Asia’s Regional strategy on prevention and containment of antimicrobial resistance (2010-2015) :
The WHO SEARO regional strategy 2010-15 recognized the need for a wide range of activities to contain antimicrobial resistance and the need for commitment from a wide variety of players. The strategy states that endorsement by all countries of the region is needed for sustained action. The strategy provides an implementation framework with suggestions of activities that could be included together with a list of suggested indicators and targets. Many of these regional indicators could be transferable to the national level. The strategy and the different indicators were followed up in regional meetings and workshops where country reports on current status and progress were presented.
In MEASURE you can find specific tools and resources for measuring various aspects of antibiotic resistance and use (for example point prevalence survey protocols and knowledge, attitudes, beliefs and practices questionnaires):
- Burden of antibiotic resistance
- Antibiotic resistance
- Consumption of antibiotics
- Appropriateness of use
- Quality of antibiotics
- Knowledge, attitudes, beliefs and practices – KABP
Analyze and communicate results
Data collected from monitoring and evaluation efforts should be analyzed by the multisectoral coordinating group and additional key stakeholders.
Results from monitoring indicators (such as input and process indicators) can aid in discussions related to future implementation strategies, whilst results from evaluation indicators (such as output, outcome or impact indicators) can also be used in future resource allocation decisions. Information for both sets are needed, as a failure of impact may be due to a failure in implementation.
Results should be fed back to collaborating partners and interested stakeholders, especially management. Communication methods and content should be tailored to the audience, and reporting should be transparent to promote confidence in the national action plan. Positive progress should be acknowledged and public recognition should be made of the contributions and successes of all partners involved in the project. Affirmation of hard work will provide incentive for stakeholders to continue to be involved in the process.
|Sample conceptual monitoring and evaluation framework for national action plans on antimicrobial resistance||Framework developed by WHO, which outlines the different steps necessary to conduct an appropriate evaluation of national action plans including: Planning, input, process, output, outcome and impact.|
|ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals||Indicators. Suggestion of outcome indicators with a ‘One Health’ perspective to assess progress made in the implementation of action plans on antimicrobial resistance. Provides rationale for selection, describes methodology, and provides example of calculation of indicators. Established by European health and food safety agencies. Examples: Human medicine: proportion of Escherichia coli bacteria resistant to third-generation cephalosporins. Veterinary medicine: proportion of E. coli in food-producing animals that are susceptible or resistant to a number of antibiotics.|
|Building Coalitions for Containing Antimicrobial Resistance: A Guide||This guide by SIAPS offers guidance on how to formulate and implement a plan and evaluate outcomes. Also provides a number of templates and sample interview forms that can be adapted for different local contexts. The chapter “Monitor and evaluate” gives an overview of the M&E process with country examples. An older version is available in Spanish and French.|
|Regional strategy on prevention and containment of antimicrobial resistance||This WHO SEARO’s 2010-2015 regional strategy on antimicrobial resistance gives a list of suggested indicators and targets that can be used on national or regional level (see chapter 7).|
|Country monitoring and evaluation guidance||Guidance from WHO to policy makers and health practitioners on how to strengthen the monitoring, evaluation and review of national health strategies. See for example “Monitoring, evaluation and review of national health strategies: a country-led platform for information and accountability, available in English, French and Spanish.|
|Guidelines for Monitoring and Evaluation of Health Sector Reforms in the African Region||This guideline was published by the WHO’s Regional Office for the African Region. It offers guidance to member states on how to integrate M&E into the process of health care planning. It also provides a background to health sector reform implementation and proposes a conceptual framework for identifying key questions and indicators for monitoring and evaluating of these reforms.|
|PVS Pathway||This pathway is a global program for the sustainable improvement of a country’s Veterinary Services’ and its compliance with OIE standards on the quality of Veterinary Service.|